Aims: Previous studies have shown that stem cell factor (SCF) induces the migration of cardiac stem cells (CSCs) and helps to repair myocardial infarctions. Earlier studies on the migration mechanism only focused on the activation of kinases; here, we aimed to explore the functional role of protein phosphatase 2A (PP2A) in SCFinduced CSC migration. Main methods: CSCs were treated with SCF, PP2A enzymatic activity was measured, the phosphorylation levels of PP2A, p38 MAPK and cofilin were evaluated using western blot. Transwell assay was used to determine the migratory ability of CSCs. Key findings: In vitro, SCF induced the phosphorylation of p38 MAPK and cofilin, leading to the migration of CSCs. Cofilin acted as a downstream signal of p38 MAPK. PP2A was involved in this process. Further studies revealed that PP2A was inactivated via phosphorylation at Tyr307 by SCF and the inactivation/phosphorylation was mediated by activated p38 MAPK, as p38 MAPK inhibitor SB203580 or siRNA prevented SCF-induced inactivation and phosphorylation of PP2A. When CSCs were pretreated with PP2A inhibitor (okadaic acid, OA), SCF-induced CSC migration and the downstream signals were enhanced, and the enhancement was reversed when p38 MAPK was blocked. Additionally, co-immunoprecipitation showed a direct interaction of PP2A with p38 MAPK. Significance: Our results indicated that PP2A regulated the SCF-induced activation of p38 MAPK/cofilin signaling pathway and subsequent migration of CSCs by interaction with p38 MAPK.
Introduction
After myocardial infarction (MI), the heart is repaired with fibrous scar tissues to compensate for the loss of functional cardiomyocytes, resulting in a lifelong effect on cardiac function. c-Kit + cardiac stem cells (CSCs) are capable of differentiating into myocytes, smooth muscle and endothelial cells [1] , and makes it a promising candidate for stem cell therapy. Despite the current controversy over stem cell therapy, clinical trials still proceed [2, 3] . In stem cell therapy, intramyocardial injection of exogenous CSCs [1, [4] [5] [6] , intracoronary infusion [7, 8] and local activation of endogenous CSCs [9, 10] are effective treatments. In all of these therapeutic methods, CSCs need to mobilize to the periinfarction area; thus, it is important to explore the underlying mechanism of CSC migration. c-Kit is usually regarded as a stem cell marker. As the ligand for ckit, stem cell factor (SCF) leads to receptor dimerization and initiation of signaling cascades involved in mediating cell survival, migration and proliferation by binding to c-kit [11] . So far the well-established signal transductions downstream of c-kit are PI3-kinase [12] , Src family kinases [13] and MAP kinases [14, 15] . In contrast to the intensive investigation into kinases in SCF/c-kit signaling, the role and regulation of phosphatases in this process have remained underexplored.
Phosphatases are divided into two broad categories: protein serine/ threonine phosphatases and protein tyrosine phosphatases [16] . Protein phosphatase 2A (PP2A) is the main soluble Ser/Thr phosphatase and most abundant in the heart [17] . Recently some studies suggested that PP2A may have a negative effect on heart function after MI, but the mechanisms are still unknown [18] [19] [20] [21] .
The PP2A holoenzyme contains a scaffolding subunit, a catalytic subunit and a variable regulatory subunit. The enzymatic activity of PP2A is modified post-translationally in two ways: phosphorylation and methylation. Phosphorylation of the catalytic subunit at Tyr307 leads to the loss of > 90% of the activity of PP2A; PP2A phosphorylation is usually a result of activation of Src family kinases, EGFR or insulin receptor [22, 23] .
PP2A is involved in many essential cellular functions -including development, cell mobility, cell cycle and cell growth [24] [25] [26] -by reversing the effects of protein kinases. For migration, PP2A likely functions at many different levels: receiving external stimuli by enhancing CXCR2 recycling [27] ; signal transduction through dephosphorylation of ERK, p38 MAPK and AKT [28, 29] , and reorganization of the cytoskeleton by associating with paxillin and cofilin [30] [31] [32] .
Although the previous studies showed a negative effect of PP2A on p38 MAPK, the role of PP2A and this relationship with p38 MAPK in CSC migration are still unclear. In general, cell migration requires significant change in cell shape which is modulated by the cytoskeleton; cofilin is an essential regulator of the cytoskeleton as cofilin severs and reorganizes filamentous-actin [33] and ultimately regulates cell migration. Subcellular localization, pH and phosphorylation all regulate the activity of cofilin [34] [35] [36] . The phosphorylation of cofilin is modified by different signals in different cells, and these signals include LIMKs, TESKs, PIP2, PP2A, SSHs, and CAP1 [37] .
In this study, we aimed to explore the role of PP2A in SCF-induced CSC migration and found that PP2A regulated CSC migration through interaction with p38 MAPK.
Materials and methods

Reagents
Antibodies against β-actin (4967), phospho-p38 MAPK (Thr180/ Thr182) (4511), phospho-cofilin (Ser3) (3313), p38 MAPK (9212), and cofilin (5175) were obtained from Cell Signaling Technology. The PP2A antibody, C subunit (05-421) was purchased from Millipore. The phospho-PP2A (Y307) (ab32104) antibody was from Abcam. The PE-CD117 (553355) and PE-IgG2b, κ isotype control (553989) antibodies were purchased from BD Pharmingen. The p38 MAPK inhibitor SB203580 (S8307) was purchased from Sigma-Aldrich. The PP2A inhibitor okadaic acid potassium salt (OA) (S1786) was obtained from Beyotime Biotechnology. The PP2A activator FTY720 (sc-202161) was obtained from Santa Cruz Biotechnology. Recombinant murine SCF (250-03-10) was purchased from Peprotech.
CSC isolation and culture
The protocol was approved by the Tongji Hospital, Huazhong University of Science and Technology Institutional Review Board of Experimental Animals. The hearts of 8-week-old C57BL/6 mice were used in CSC isolation as described previously [5, 38] with minor modifications. In summary, mice were sacrificed and hearts were isolated. The hearts were minced into very small pieces and washed twice with cold PBS. The tissue fragments were digested with 5 ml of Liberase TH (Roche, 05401135001) for 10 min, and then were planted and cultured in Ham's F12 medium containing 10% FBS, 0.1 mM 2-ME, 2 mM L-Glu and 100 U/ml antibiotics. After two weeks, cells migrated from the explants were collected and selected by magnetic bead selection (Stem Cell, 18556) according to the manufacturer's manual. These obtained cells were cultured in DMEM/F-12 medium supplemented with 10% FBS, 10 ng/ml LIF, 20 ng/ml bFGF, 10 ng/ml EGF, insulin-transferrinselenite and 100 U/ml antibiotics, and were used for subsequent experiments.
Flow cytometry
A PE-c-kit monoclonal antibody was added to the single cell suspension, the PE-IgG2b, κ isotype was used as negative control. After incubation for 30 min on ice in the dark, cells were then washed and resuspended in 200 μl cold PBS. The stained cell samples were analyzed by flow cytometry (BD Biosciences, FACSCalibur).
Cell transfection
The cofilin small interfering RNA (siRNA) (4390771) and Silencer Select Negative Control siRNA (4390843) were from Ambion. The p38 MAPK siRNA (siG0957171300) was obtained from Ribobio. CSCs were transfected with siRNA at 50-70% confluence using RNAiMAX (Invitrogen, 13778-150) and were harvested 48 h after transfection.
Western blot
CSCs were lysed with RIPA buffer (Sigma, R0278) containing Inhibitor Cocktails. Lysates were collected and centrifuged for 15 min at 4°C to obtain the supernatant. The protein concentrations were then determined with BCA Protein Assay Kit (Pierce, 23227). Samples were separated by 12% SDS-PAGE gel electrophoresis, transferred onto NC Membranes (Millipore, HATF000010), and incubated with the following antibodies: antibodies against phospho-p38 MAPK (1:1000), phospho-PP2A (1:5000), phospho-cofilin (1:1000), p38 MAPK (1:1000), PP2A (1:3000), cofilin (1:1000), β-actin (1:1000) overnight at 4°C. After incubating with corresponding HRP-labeled secondary antibodies, protein signals were visualized by a chemiluminescence imaging system (Syngene, GeneGnomeXRQ).
Transwell migration assay
To determine the migratory ability of CSCs, 24-well transwell plates (Corning, 3422) were used; 600 μl of medium alone or with 10, 30, 50, 100, and 150 ng/ml recombinant murine SCF was placed in the 24-well The results are presented as the mean ± SEM. n = 3. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control. The results are presented as the mean ± SEM. n = 3. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control; △P < 0.05 and △△△P < 0.001 vs. SCF; n.s. not significant vs. SCF.
plate well, 3 × 10 4 CSCs were suspended with 100 μl of medium and added to the Transwell insert. For the inhibition experiment, CSCs were pretreated with cofilin siRNA for 48 h, 100 nM FTY720 for 24 h or an inhibitor (20 μΜ SB203580 for p38 MAPK, 100 nM OA for PP2A) for 1 h before being seeded into the upper chamber. After incubating for 12 h at 37°C, cells were fixed and stained with crystal violet for 10 min, and then the cells that had not migrated were removed from the Transwell insert with a wet cotton swab. Images of cells that had migrated to the lower side of the membrane were acquired in nine randomly-selected fields (×200 high-power fields) under an inverted microscope (Olympus, CKX41). The numbers of the cells were counted with ImageJ 1.42q and the data were expressed as Migration Index: the number of cells that migrated in response to stimulation relative to the number of cells that migrated randomly (medium only).
PP2A enzymatic activity
PP2A enzymatic activity was assayed according to the instruction of Serine/Threonine Phosphatase Assay System (Promega, V2460). In summary, cell lysates were added to the provided spin columns with Sephadex beads to remove endogenous phosphates. The lysates were then normalized for protein content. The reaction was initiated by adding 15 μl of reaction premixes containing 5 μl of 1 mM phosphopeptide and 10 μl of PPase-2A 5× reaction buffer. After incubating at 37°C for 10 min, 50 μl of molybdate dye/additive mixture was added to the well in order to terminate the enzymatic reaction. The absorbance of the sample was measured at 630 nm. Phosphatase activity of the sample was calculated with the phosphate standard curve.
Immunoprecipitation
Immunoprecipitation was performed following the instructions of the Crosslink Immunoprecipitation Kit (Pierce, 26147). Briefly, 10 μg of an anti-PP2A or mouse IgG antibody was bound to protein A/G agarose. Disuccinimidyl Suberate (DSS) was used to crosslink the bound antibodies. CSCs were lysed by IP Lysis Buffer. The supernatants were precleared with the Control Agarose Resin, and they were then added to the antibody-crosslinked resin. After overnight incubation with endover-end mixing at 4°C, the samples were washed 3 times with IP Lysis Buffer and once with Conditioning Buffer, then were eluted using the Elution Buffer and analyzed by western blotting.
Statistical analysis
The results are represented as the mean ± SEM. One-way ANOVA followed by the post hoc Tukey test was employed for multi-group comparison. P < 0.05 was considered significance.
Results
PP2A is involved in SCF/p38 MAPK/cofilin-induced CSC migration
CSCs were sorted with immunomagnetic beads from the outgrowth of heart tissue. The acquired cells continued to grow for at least 1 month, then the percentage of c-kit + cells was measured by flow cytometry (Fig. 1A) ; the majority of experiments were concluded within 1 month [5] . Transwell migration assay was used to detect the effect of SCF on CSC migration. After culture for 12 h, the average number of migrated CSCs was significantly increased with 50, 100, and 150 ng/ml of SCF compared to the control; the maximum response was observed at 100 ng/ml (Fig. 1B) .
Our previous work has shown that p38 MAPK is a pivotal kinase mediating SCF-induced CSC migration [39, 40] . However, its downstream cytoskeletal protein involved in CSC migration is not known yet. Cofilin is the major regulator of cell migration that can sever, depolymerize and disassemble F-actin [33] . In Fig. 2A , phosphorylation of p38 MAPK and cofilin was observed in CSCs treated with 100 ng/ml SCF for different times. Phospho-p38 MAPK peaked immediately after 5 min of SCF stimulation. Phospho-cofilin peaked at 10 min. Both markers remained elevated for at least 60 min. SB203580 is a p38 MAPK inhibitor which restrains the kinase activity of p38 MAPK without affecting its phosphorylation [41] . Inhibition the p38 MAPK activity with 20 μM SB203580 or knockdown of p38 MAPK with siRNA significantly suppressed SCF-induced cofilin phosphorylation (Fig. 2B, C) and CSC migration (Fig. 2E) . Knockdown of cofilin by siRNA transfection did not affect p38 MAPK phosphorylation but inhibited CSC migration in the presence of SCF (Fig. 2D, E ). All data above indicated that SCF induced CSC migration via sequential phosphorylation of p38 MAPK and then cofilin.
So far, numerous studies have shown that kinases are widely Fig. 3 . PP2A participates in CSC migration in response to SCF. CSCs were treated with 100 nM OA for 1 h or 100 nM FTY720 for 24 h and then were added to the upper chamber. Medium with or without 100 ng/ml SCF was in the lower chamber. Representative images (A) and cumulative data (B) were shown. The results are presented as the mean ± SEM. n = 3. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control; △△△P < 0.001 vs. SCF.
involved in SCF-induced migration [12] [13] [14] [15] , while the function of phosphatases has remained underexplored. Previous studies have revealed that PP2A, the most abundant phosphatase in the heart, is associated with p38 MAPK or cofilin [28, 37] . Therefore, it would be interesting to study the function of PP2A in SCF-stimulated CSC migration. CSCs were pretreated with PP2A inhibitor OA or PP2A activator FTY720, and then submitted to a transwell assay, CSC migration was notably enhanced by OA pre-incubation and inhibited by FTY720 with or without the stimulation of SCF (Fig. 3) . These results indicated that PP2A activity regulated SCF-mediated CSC migration.
PP2A is inactivated by SCF-induced phosphorylation of p38 MAPK
Recent studies have shown that cells with activated c-kit mutant had a relatively low activity of PP2A [42, 43] , suggesting a possible effect of SCF/c-kit on PP2A activity. Considering that the activity of PP2A mainly regulated by phosphorylation of the catalytic subunit at Tyr307, next we studied whether SCF/c-kit regulated enzymatic activity and phosphorylation of PP2A.
CSCs were treated with 100 ng/ml of SCF for different times (0, 5, 10, 20, 30, and 60 min), PP2A enzymatic activity was found to be decreased after 30 or 60 min of incubation (Fig. 4A ). Correspondingly, the phosphorylation level of PP2A at Tyr307 was increased (Fig. 4B) . Moreover, blocking p38 MAPK with the p38 MAPK inhibitor or siRNA reversed the PP2A inactivation and phosphorylation in SCF stimulated CSCs (Fig. 4C, D, E, F) . Taken together, our data demonstrated that PP2A was inactivated by the phosphorylation of p38 MAPK, but not SCF receptor-tyrosine kinase c-kit. Fig. 4 . SCF-dependent PP2A inactivation via phosphorylation requires p38 MAPK. Effects of SCF on PP2A were assessed with PP2A enzymatic activity and phosphorylation level of PP2A respectively. (A, B) CSCs were treated with 100 ng/ml SCF for the indicated times (0, 5, 10, 20, 30, and 60 min). (C, D) CSCs were pretreated with 20 μM SB203580 or vehicle for 1 h followed by treatment with 100 ng/ml SCF for 30 min. (E, F) CSCs were transfected with p38 MAPK siRNA for 48 h prior to treatment with 100 ng/ml SCF for 30 min. The results are presented as the mean ± SEM. n = 3. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control; △P < 0.05 and △△P < 0.01 vs. SCF.
Inactivation of PP2A enhances SCF-induced migration and cofilin phosphorylation by strengthening the phosphorylation of p38 MAPK
To further investigate the effects of the inactivated PP2A, OA (PP2A inhibitor) and FTY720 (PP2A activator) were used to alter the activity of PP2A, and then the SCF induced phosphorylation of p38 MAPK and cofilin was measured by western blot. We found that compared with control (only SCF stimulated), FTY720 pre-incubation partially inhibited SCF-induced phosphorylation of both p38 MAPK and cofilin (Fig. 5A) , and on the contrary, PP2A inhibitor OA promoted the phosphorylation of p38 MAPK and cofilin stimulated by SCF (Fig. 5B) . Besides, the phosphorylation levels of p38 MAPK were enhanced in CSCs by the OA treatment in a dose-dependent manner, both at basal level and in the presence of SCF (Fig. S1) . Together with Fig. 2 , we demonstrated that PP2A regulated SCF-induced CSC migration by regulating phosphorylation of p38 MAPK and cofilin.
To explore the detailed regulatory mechanism of PP2A, CSCs were first pretreated with p38 MAPK inhibitor, the promotive effect of OA on SCF-induced phosphorylation of cofilin was reversed (Fig. 6A) . Similarly, in transwell migration assay, the OA-associated promotion of SCFinduced migration (Fig. 6B-2 ) was totally abolished upon pretreatment of the p38 MAPK inhibitor SB203580 (Fig. 6B-3) or the cofilin siRNA (Fig. 6B-4) before OA exposure. These results suggested that the inactivation of PP2A enhanced p38 MAPK phosphorylation, which led to the increase of SCF-induced phosphorylation of cofilin and CSC migration. To further investigate the relationship between PP2A and p38 MAPK, CSCs were incubated with 100 ng/ml SCF for 30 min, PP2A was immunoprecipitated from cell lysates and p38 MAPK-PP2A co-precipitation was confirmed. Cofilin was not detected in the PP2A immunoprecipitates (Fig. 6C) . The above data demonstrated that PP2A directly interacted with p38 MAPK and thus regulated SCF-induced CSC migration.
Discussion
According to our previous studies, SCF is of great importance to cardiac remodeling after MI through CSC recruitment [39, 40] . Currently, several studies have shown that activation of kinases, such as p38 MAPK, ERK1/2, and AKT, contributes to SCF-induced migration [44, 45] . By contrast, the role of phosphatases has not been studied. Here, we presented evidence that PP2A, the major phosphatase present in the heart, was involved in SCF-induced migration (Fig. 7) .
We found that SCF-induced CSC migration occurred in vitro. Cofilin is an important actin-binding protein that is involved in cell migration Fig. 5 . Effect of PP2A on p38 MAPK/cofilin activation in presence of SCF. CSCs were pretreated with 100 nM OA for 1 h (A) or 100 nM FTY720 for 24 h (B) followed by treatment with 100 ng/ml SCF for 30 min. The expression of phospho-p38 MAPK and phospho-cofilin were determined by Western blot analysis. The results are presented as the mean ± SEM. n = 3. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control; △P < 0.05 and △△P < 0.01 vs. SCF; #P < 0.05 vs. FTY720. by disassembling actin filaments. Our previous work showed that SCF mediated CSC migration via activating p38 MAPK [39] . Here, we further demonstrated that cofilin acted as a downstream signaling effector of p38 MAPK while engaging in SCF-induced migration. Although, Chacon-Martinez et al. have reported that with 20 ng/ml SCF stimulation cofilin dephosphorylated via SWAP-70 during the bone marrowderived mast cell reorganization of F-actin networks [46] , we were surprised to find that SCF upregulated the phosphorylation level of cofilin in a time-dependent manner: the expression level of phosphocofilin peaked rapidly at 10 min and remained at this level for at least 60 min. This phosphorylation of cofilin following SCF stimulation was through activation of p38 MAPK. The controversy may be explained by the differences of cell type, SCF concentration used or upstream activator of cofilin engaged.
It has been well established that PP2A regulates cell migration at many different levels, but there is no evidence that PP2A is involved in the SCF-induced migration of CSCs. Recent investigations have shown that the activity of PP2A was decreased in myeloid cells expressing activated c-kit mutant [42, 43] , suggesting a possible relationship between SCF/c-kit and PP2A. Thus, we measured the PP2A activity in CSCs treated with 100 ng/ml SCF for different times. The results showed that SCF suppressed PP2A enzymatic activity in a time-dependent manner. Phosphorylation and methylation of the catalytic subunit mediate PP2A catalytic activity; phosphorylation of the catalytic subunit at Tyr307 plays the most predominant role in modulating the PP2A catalytic activity, thus, we measured the phosphorylation level of PP2A in presence of SCF. We found that PP2A phosphorylation was accompanied by the decrease of enzymatic activity. Both SCF-induced inactivation and phosphorylation of PP2A occurred later than the phosphorylation of p38 MAPK and cofilin. A p38 MAPK inhibitor or siRNA prevented the SCF-induced PP2A inactivation and phosphorylation, suggesting that SCF inactivated PP2A through activation of p38 MAPK instead of through its receptor c-kit.
To further explore the potential signal pathway that PP2A is involved in, OA and FTY720 were administered to CSCs. OA is an inhibitor of PP1 and PP2A, and at a concentration of 100 nM, OA selectively inhibits the enzymatic activity of PP2A [47] . FTY720 is a sphingosine analog and is a widely used PP2A activator [42, 48] . The increased expressions of both phospho-p38 MAPK and phospho-cofilin induced by SCF were partially decreased by FTY720 and further strengthened by OA. Furthermore, following inhibition of p38 MAPK activity with SB203580, the OA-associated enhancements of SCF-induced migration and cofilin phosphorylation were reversed. Additionally, using immunoprecipitation, we found that PP2A associated with p38 MAPK, but not with cofilin. These data collectively confirmed that PP2A interacted with p38 MAPK and subsequently enhanced SCFinduced migration. Many studies have shown a unidirectional connection between PP2A and p38 MAPK [49] [50] [51] [52] . Here, we provided evidence that PP2A interacted with p38 MAPK: SCF inactivated PP2A through p38 MAPK and then inactivated PP2A led to an increase of the level of phospho-p38 MAPK. There was no evidence that PP2A directly interacted with cofilin.
Moreover, we unexpectedly found that even without the stimulation of SCF, OA and FTY720 still regulated CSC migration. However, the phosphorylation of cofilin remained unchanged under these conditions. Thus, we inferred that in the absence of SCF, PP2A regulated the migration of CSCs through a different mechanism.
During the past decade, stem cell therapy becomes an attractive treatment of heart disease, as numerous studies have shown that CSCs recruited to the peri-infarcted area and helped to improve cardiac function. But its development is limited by the poor understanding of stem cell behavior and controversial outcomes of clinical trials. Our study further improved the mechanism of SCF-induced CSC migration, and the importance of PP2A provided a new insight into the administration of SCF, which has been proved to recruit CSCs in vivo effectively [53, 54] .
Conclusions
Our study revealed the importance of PP2A in SCF-mediated CSC migration. SCF mobilized CSCs through p38 MAPK/cofilin signal pathway and PP2A played a significant role in regulating this process. SCF induced phosphorylation of PP2A, causing suppression of PP2A enzymatic activity, through p38 MAPK. The inactivation of PP2A enhanced p38 MAPK/cofilin signaling pathway, ultimately promoting SCF-induced CSC migration. Our findings suggest that PP2A may be a potential target for enhancing CSC migration.
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